Heart Failure Drugs Market Growth Drivers and Opportunities by 2028

The heart failure drugs market is expected to gain market growth in the forecast period of 2021 to 2028. Data bridge market research analyses that the market is growing with the CAGR of 15.56% in the forecast period of 2021 to 2028 and is expected to reach USD 18,660.58 million by 2028. The increase in prevalence of cardiovascular disease among population across the globe is escalating the growth of heart failure drugs market.

Heart failure refers to complex clinical syndrome having certain signs and symptoms which are result of structural and functional cardiac aberrations. The treatment of this syndrome is dependent on angiotensin-converting enzyme inhibitor, angiotensin receptor II blocker, beta-blockers and diuretics. The heart failure drugs work in various ways in case of heart attack such as ACE inhibitors prevents the formation of angiotensin which causes blood vessels to constrict, angiotensin helps in lowering the effect of angiotensin on the heart and beta blockers block the actions of certain chemicals.

The increase in rate of cardiovascular cases among people and the growing geriatric population globally are the major factors driving the heart failure drugs market. The increase in need of these drugs as they treat different symptoms of the disorder and the dependency of the patients on these drugs accelerates the heart failure drugs market growth. The change in lifestyle such as excessive alcohol consumption, smoking and unhealthy diet habits causes heart problems which is propelling the heart failure drugs market. The increase in investment by key players and the increase in number of research and development activities influence the heart failure drugs market.

Request a Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-heart-failure-drugs-market

North America dominates the heart failure drugs market because of the rise in the rate of cardiovascular disorders, increasing obesity cases among people and growing healthcare expenditure. Asia-Pacific is expected to witness the highest CAGR in the forecast period of 2021-2028 because of the growing patient pool, initiatives by the government to enhance quality of healthcare, rise in cardiovascular disorder cases and increase in disposable income in the region.

The major players covered in the heart failure drugs market report are Amgen Inc., AstraZeneca, Bayer AG, Novartis AG, Gilead Sciences, Inc, GlaxoSmithKline plc, Pfizer Inc., Teva Pharmaceutical Industries Ltd, Cardurion Pharmaceuticals, Cardior Pharmaceuticals, Actelion Pharmaceuticals Ltd, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, CYTOKINETICS, INC., Eli Lilly and Company, Merck Sharp & Dohme Corp., Quantum Genomics, RENOVA, SERVIER LABORATORIES, Stealth BioTherapeutics Inc., Sanofi, Mylan N.V., Bausch Health Companies Inc. among other domestic and global players.

Related Reports:

Global Pediatric Mechanical Heart Valve Market https://www.databridgemarketresearch.com/reports/global-pediatric-mechanical-heart-valve-market

Global Heart Valve Devices Market https://www.databridgemarketresearch.com/reports/global-heart-valve-devices-market

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”

Contact: 

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Corporatesales@databridgemarketresearch.com

Article source: https://article-realm.com/article/Health-Fitness/44820-Heart-Failure-Drugs-Market-Growth-Drivers-and-Opportunities-by-2028.html